Polymorphisms in the insulin-like growth factor axis are associated with gastrointestinal cancer

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Ong, Jennie ^a   Salomon, Jody ^a   Te Morsche, Rene H M ^a   Roelofs, Hennie M J ^a   Witteman, Ben J M ^b   Dura, Polat ^a   Lacko, Martin ^c   Peters, Wilbert H M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GELDERSE VALLEI HOSPITAL   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE RECEPTOR; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DNA ISOLATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENETIC ASSOCIATION; GENOTYPE; GHR GENE; HEAD AND NECK CANCER; HUMAN; INSULIN LIKE GROWTH FACTOR TYPE 1 GENE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; ADENOCARCINOMA; ALLELE; COLORECTAL TUMOR; ESOPHAGUS TUMOR; GENE EXPRESSION; GENE FREQUENCY; GENETICS; HEAD AND NECK TUMOR; MIDDLE AGED; PATHOLOGY; RISK; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AGED; ALLELES; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; HEAD AND NECK NEOPLASMS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; NETHERLANDS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, SOMATOTROPIN; SEX FACTORS;

EID: 84897552607     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090916     Document Type: Article

References (35)

1. IARC, Lyon, France. GLOBOCAN 2008. Section of Cancer Information. Available: http://globocan.iarc.fr/factsheets/populations/factsheet. asp?uno = 900.
2. Integraal Kankercentrum Nederland. Cijfers over Kanker. Available: http://www.cijfersoverkanker.nl/selecties/dataset-1/img51729ed128e20.
3. Ho SM, Ho JW, Chan CL, Kwan K, Tsui YK (2003) Decisional consideration of hereditary colon cancer genetic test results among Hong Kong chinese adults. Cancer Epidemiol Biomarkers Prev 12: 426-432. (Pubitemid 36578480)
4. Zhivotovskiy AS, Kutikhin AG, Azanov AZ, Yuzhalin AE, Magarill YA, et al. (2012) Colorectal cancer risk factors among the population of South-East Siberia: a case-control study. Asian Pac J Cancer Prev 13: 5183-5188.
5. Haggar FA, Boushey RP (2009) Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 22: 191-197.
6. Chhabra Y, Waters MJ, Brooks AJ (2010) Role of the growth hormone-IGF-1 axis in cancer. Expert Rev Endocrinol Metab 6: 71-84.
7. Samani AA, Yakar S, LeRoith D, Brodt P (2007) The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28: 20-47. (Pubitemid 46220849)
8. LeRoith D, Roberts CT Jr (2003) The insulin-like growth factor system and cancer. Cancer Lett 195: 127-137. (Pubitemid 36588961)
9. Denley A, Cosgrove LJ, Booker GW, Wallace JC, Forbes BE (2005) Molecular interactions of the IGF system. Cytokine Growth Factor Rev 16: 421-439. (Pubitemid 41022012)
10. Estivariz CF, Ziegler TR (1997) Nutrition and the insulin-like growth factor system. Endocrine 7: 65-71. (Pubitemid 127483089)
11. Yu H, Rohan T (2000) Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 92: 1472-1489.
12. Gallagher EJ, LeRoith D (2011) Minireview: IGF, Insulin, and Cancer. Endocrinology 152: 2546-2551.
13. Macaulay VM (1992) Insulin-like growth factors and cancer. Br J Cancer 65: 311-320.
14. Ionescu M, Frohman LA (2006) Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab 91: 4792-4797. (Pubitemid 44917309)
15. Kaskel F (2003) Chronic renal disease: a growing problem. Kidney Int 64: 1141-1151. (Pubitemid 37013858)
16. Hwa V, Oh Y, Rosenfeld RG (1999) The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 20: 761-787. (Pubitemid 30648894)
17. McElholm AR, McKnight AJ, Patterson CC, Johnston BT, Hardie LJ, et al. (2010) A population-based study of IGF axis polymorphisms and the esophageal inflammation, metaplasia, adenocarcinoma sequence. Gastroenterology 139: 204-212.
18. Hernandez W, Grenade C, Santos ER, Bonilla C, Ahaghotu C, et al. (2007) IGF-1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-Americans. Carcinogenesis 28: 2154-2159. (Pubitemid 47543376)
19. Canzian F, McKay JD, Cleveland RJ, Dossus L, Biessy C, et al. (2006) Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. Br J Cancer 94: 299-307. (Pubitemid 43151551)
20. Bonapace G, Concolino D, Formicola S, Strisciuglio P (2003) A novel mutation in a patient with insulin-like growth factor 1 (IGF1) deficiency. J Med Genet 40: 913-917. (Pubitemid 38117542)
21. Zhao J, Xiong DH, Guo Y, Yang TL, Recker RR, et al. (2007) Polymorphism in the insulin-like growth factor 1 gene is associated with age at menarche in caucasian females. Hum Reprod 22: 1789-1794. (Pubitemid 47055172)
22. Kim HJ, Kim SK, Park HJ, Chung JH, Chun J, et al. (2012) Polymorphisms of IGFI contribute to the development of ischemic stroke. Exp Ther Med 3: 93-98.
23. Chatterjee S, Pal JK (2009) Role of 59-and 39-untranslated regions of mRNAs in human diseases. Biol Cell 101: 251-262.
24. NCBI. Reference SNP (refSNP) Cluster Report: rs6214. Available: http://www. ncbi.nlm.nih.gov/projects/SNP/snp-ref.cgi?rs = 6214.
25. NCBI. Reference SNP (refSNP) Cluster Report: rs6898743. Available: http://www.ncbi.nlm.nih.gov/projects/SNP/snp-ref.cgi?rs = 6898743.
26. Feik E, Baierl A, Hieger B, Führlinger G, Pentz A, et al. (2010) Association of IGF1 and IGFBP3 polymorphisms with colorectal polyps and colorectal cancer risk. Cancer Causes Control 21: 91-97.
27. Estores D, Velanovich V (2013) Barrett esophagus: epidemiology, pathogenesis, diagnosis, and management. Curr Probl Surg 50: 192-226.
28. Nakao M, Hosono S, Ito H, Watanabe M, Mizuno N, et al. (2011) Interaction between IGF-1 polymorphisms and overweight for the risk of pancreatic cancer in Japanese. Int J Mol Epidemiol Genet 2: 354-366.
29. Ma J, Pollak M, Giovannucci E, Chan JM, Tao Y, et al. (2000) A prospective study of plasma levels of insulin-like growth factor I (IGF-I) and IGF-binding protein-3, and colorectal cancer risk among men. Growth Horm IGF Res 10 Suppl A: S28-29. (Pubitemid 30641924)
30. Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, et al. (2000) A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 9: 345-349. (Pubitemid 30265776)
31. Al-Zahrani A, Sandhu MS, Luben RN, Thompson D, Baynes C, et al. (2006) IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Hum Mol Genet 15: 1-10. (Pubitemid 43020099)
32. D'Aloisio AA, Schroeder JC, North KE, Poole C, West SL, et al. (2009) IGF-I and IGFBP-3 polymorphisms in relation to circulating levels among African American and Caucasian women. Cancer Epidemiol Biomarkers Prev 18: 954-966.
33. Boeing H (2013) Obesity and cancer-The update 2013. Best Pract Res Clin Endocrinol Metab 27: 219-227.
34. Renehan AG, Frystyk J, Flyvbjerg A (2006) Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab 17: 328-336. (Pubitemid 44397568)
35. Kelemen LE, Sellers TA, Vachon CM (2008) Can genes for mammographic density inform cancer aetiology? Nat Rev Cancer 8: 812-823.